The retatrutide availability guide stays updated on supply changes and market developments
doi:10.1016/j.mce.2019.110579
Davies M, Frch L, Jeppesen OK et al (2021) Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
This basic blood test measures sodium, potassium, chloride, calcium, and bicarbonate levels
The most recent and methodologically rigorous of them, restricted to four placebo-controlled trials in 667 patients, found no significant difference from placebo on MDS-UPDRS Part III in either the on- or off-medication state [7]